Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by TCW Group Inc.

TCW Group Inc. increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 6.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,368 shares of the company’s stock after acquiring an additional 1,628 shares during the period. TCW Group Inc.’s holdings in Henry Schein were worth $1,922,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Toronto Dominion Bank increased its position in Henry Schein by 68.3% in the 3rd quarter. Toronto Dominion Bank now owns 62,779 shares of the company’s stock valued at $4,577,000 after acquiring an additional 25,474 shares during the period. M&T Bank Corp increased its holdings in shares of Henry Schein by 4.5% during the third quarter. M&T Bank Corp now owns 10,990 shares of the company’s stock valued at $802,000 after purchasing an additional 472 shares during the period. Barclays PLC raised its stake in shares of Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company’s stock valued at $20,882,000 after purchasing an additional 18,458 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its stake in shares of Henry Schein by 1.0% during the third quarter. Nomura Asset Management Co. Ltd. now owns 38,816 shares of the company’s stock valued at $2,830,000 after purchasing an additional 373 shares in the last quarter. Finally, MML Investors Services LLC lifted its holdings in Henry Schein by 5.1% in the third quarter. MML Investors Services LLC now owns 11,000 shares of the company’s stock worth $802,000 after purchasing an additional 535 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.14% of the stock is currently owned by insiders.

Henry Schein Price Performance

HSIC stock opened at $77.03 on Friday. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The firm has a 50-day moving average of $72.12 and a two-hundred day moving average of $70.03. The firm has a market capitalization of $9.60 billion, a PE ratio of 31.70, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the firm earned $1.32 EPS. The firm’s quarterly revenue was up .4% on a year-over-year basis. On average, analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have commented on HSIC. Barrington Research reissued an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Mizuho initiated coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Evercore ISI upped their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $78.89.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.